SUNNYVALE, Calif., Aug. 30 /PRNewswire-FirstCall/ -- Cepheid will present at the Thomas Weisel Partners Healthcare Conference being held at the Four Seasons Hotel, Boston, September 5 to 7, 2007. Chief Executive Officer John L. Bishop and Senior Vice President, Finance and Chief Financial Officer, John R. Sluis will present at 9:10 a.m. ET on September 7.
The webcast, along with accompanying presentation slides, may also be accessed on Cepheid's Web site at http://www.cepheid.com under Investors: Events: Webcasts and Presentations. A replay of the webcast presentation will be available for 90 days.
About Cepheid
Cepheid , based in Sunnyvale, California, is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.cepheid.com for more information.
CepheidCONTACT: John L. Bishop, CEO, john.bishop@cepheid.com, or John R. Sluis,CFO, john.sluis@cepheid.com, both of Cepheid, +1-408-541-4191; or Media,Chris Stamm of Schwartz Communications, +1-781-684-0770,cepheid@schwartz-pr.com, for Cepheid; or Investors, Jason Spark of PorterNovelli Life, +1-619-849- 6005, jspark@pnlifesciences.com, for Cepheid
Web site: http://www.cepheid.com/
